nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—Irreversible renal failure—Cisplatin—testicular cancer	0.105	0.169	CcSEcCtD
Triamterene—SCNN1G—seminal vesicle—testicular cancer	0.0733	0.194	CbGeAlD
Triamterene—SCNN1D—gonad—testicular cancer	0.053	0.14	CbGeAlD
Triamterene—SCNN1B—gonad—testicular cancer	0.0448	0.119	CbGeAlD
Triamterene—Renal failure chronic—Ifosfamide—testicular cancer	0.0428	0.0687	CcSEcCtD
Triamterene—SCNN1D—testis—testicular cancer	0.0382	0.101	CbGeAlD
Triamterene—Renal failure chronic—Cisplatin—testicular cancer	0.0369	0.0593	CcSEcCtD
Triamterene—SCNN1A—female gonad—testicular cancer	0.0336	0.089	CbGeAlD
Triamterene—SCNN1B—testis—testicular cancer	0.0323	0.0854	CbGeAlD
Triamterene—SCNN1A—testis—testicular cancer	0.0298	0.0789	CbGeAlD
Triamterene—SCNN1D—lymph node—testicular cancer	0.0277	0.0733	CbGeAlD
Triamterene—SCNN1B—lymph node—testicular cancer	0.0234	0.0619	CbGeAlD
Triamterene—Anaemia megaloblastic—Methotrexate—testicular cancer	0.0231	0.0372	CcSEcCtD
Triamterene—SCNN1A—lymph node—testicular cancer	0.0216	0.0572	CbGeAlD
Triamterene—Tubulointerstitial nephritis—Ifosfamide—testicular cancer	0.015	0.0242	CcSEcCtD
Triamterene—Renal failure acute—Chlorambucil—testicular cancer	0.0137	0.022	CcSEcCtD
Triamterene—Azotaemia—Methotrexate—testicular cancer	0.0102	0.0164	CcSEcCtD
Triamterene—Hyperkalaemia—Cisplatin—testicular cancer	0.00976	0.0157	CcSEcCtD
Triamterene—Jaundice—Chlorambucil—testicular cancer	0.0095	0.0153	CcSEcCtD
Triamterene—Renal failure acute—Ifosfamide—testicular cancer	0.00906	0.0146	CcSEcCtD
Triamterene—Renal failure acute—Cisplatin—testicular cancer	0.00781	0.0126	CcSEcCtD
Triamterene—Hypokalaemia—Ifosfamide—testicular cancer	0.00761	0.0122	CcSEcCtD
Triamterene—Hypokalaemia—Cisplatin—testicular cancer	0.00656	0.0105	CcSEcCtD
Triamterene—Thrombocytopenia—Chlorambucil—testicular cancer	0.00609	0.00978	CcSEcCtD
Triamterene—Thrombocytopenia—Vinblastine—testicular cancer	0.00558	0.00896	CcSEcCtD
Triamterene—Fatigue—Chlorambucil—testicular cancer	0.00536	0.00861	CcSEcCtD
Triamterene—Hyperkalaemia—Epirubicin—testicular cancer	0.00501	0.00805	CcSEcCtD
Triamterene—Jaundice—Etoposide—testicular cancer	0.00496	0.00797	CcSEcCtD
Triamterene—Blood urea increased—Epirubicin—testicular cancer	0.00482	0.00774	CcSEcCtD
Triamterene—Anaphylactic shock—Bleomycin—testicular cancer	0.00481	0.00773	CcSEcCtD
Triamterene—Thrombocytopenia—Bleomycin—testicular cancer	0.00471	0.00757	CcSEcCtD
Triamterene—Hyperkalaemia—Doxorubicin—testicular cancer	0.00464	0.00745	CcSEcCtD
Triamterene—Hypersensitivity—Chlorambucil—testicular cancer	0.00458	0.00736	CcSEcCtD
Triamterene—Photosensitivity—Methotrexate—testicular cancer	0.00451	0.00724	CcSEcCtD
Triamterene—Asthenia—Chlorambucil—testicular cancer	0.00446	0.00717	CcSEcCtD
Triamterene—Blood urea increased—Doxorubicin—testicular cancer	0.00446	0.00716	CcSEcCtD
Triamterene—Thrombocytopenia—Dactinomycin—testicular cancer	0.00439	0.00706	CcSEcCtD
Triamterene—Renal failure acute—Methotrexate—testicular cancer	0.00429	0.00689	CcSEcCtD
Triamterene—Diarrhoea—Chlorambucil—testicular cancer	0.00425	0.00683	CcSEcCtD
Triamterene—Photosensitivity—Epirubicin—testicular cancer	0.00422	0.00678	CcSEcCtD
Triamterene—Hypersensitivity—Vinblastine—testicular cancer	0.0042	0.00674	CcSEcCtD
Triamterene—Anaphylactic shock—Ifosfamide—testicular cancer	0.00411	0.00661	CcSEcCtD
Triamterene—Asthenia—Vinblastine—testicular cancer	0.00409	0.00657	CcSEcCtD
Triamterene—Thrombocytopenia—Ifosfamide—testicular cancer	0.00403	0.00647	CcSEcCtD
Triamterene—Renal failure acute—Epirubicin—testicular cancer	0.00401	0.00645	CcSEcCtD
Triamterene—Vomiting—Chlorambucil—testicular cancer	0.00395	0.00635	CcSEcCtD
Triamterene—Photosensitivity—Doxorubicin—testicular cancer	0.0039	0.00627	CcSEcCtD
Triamterene—Diarrhoea—Vinblastine—testicular cancer	0.0039	0.00626	CcSEcCtD
Triamterene—Fatigue—Dactinomycin—testicular cancer	0.00387	0.00622	CcSEcCtD
Triamterene—Dizziness—Vinblastine—testicular cancer	0.00377	0.00605	CcSEcCtD
Triamterene—Renal failure acute—Doxorubicin—testicular cancer	0.00371	0.00596	CcSEcCtD
Triamterene—Nausea—Chlorambucil—testicular cancer	0.00369	0.00593	CcSEcCtD
Triamterene—Vomiting—Vinblastine—testicular cancer	0.00362	0.00582	CcSEcCtD
Triamterene—Headache—Vinblastine—testicular cancer	0.00357	0.00573	CcSEcCtD
Triamterene—Fatigue—Ifosfamide—testicular cancer	0.00354	0.0057	CcSEcCtD
Triamterene—Anaphylactic shock—Cisplatin—testicular cancer	0.00354	0.00569	CcSEcCtD
Triamterene—Hypersensitivity—Bleomycin—testicular cancer	0.00354	0.00569	CcSEcCtD
Triamterene—Thrombocytopenia—Cisplatin—testicular cancer	0.00347	0.00558	CcSEcCtD
Triamterene—Asthenia—Bleomycin—testicular cancer	0.00345	0.00555	CcSEcCtD
Triamterene—Nausea—Vinblastine—testicular cancer	0.00338	0.00544	CcSEcCtD
Triamterene—Hypokalaemia—Epirubicin—testicular cancer	0.00337	0.00542	CcSEcCtD
Triamterene—Hypersensitivity—Dactinomycin—testicular cancer	0.00331	0.00531	CcSEcCtD
Triamterene—Anaphylactic shock—Etoposide—testicular cancer	0.00325	0.00522	CcSEcCtD
Triamterene—Asthenia—Dactinomycin—testicular cancer	0.00322	0.00517	CcSEcCtD
Triamterene—Thrombocytopenia—Etoposide—testicular cancer	0.00318	0.00511	CcSEcCtD
Triamterene—Photosensitivity reaction—Methotrexate—testicular cancer	0.00312	0.00502	CcSEcCtD
Triamterene—Hypokalaemia—Doxorubicin—testicular cancer	0.00312	0.00501	CcSEcCtD
Triamterene—Diarrhoea—Dactinomycin—testicular cancer	0.00307	0.00493	CcSEcCtD
Triamterene—Vomiting—Bleomycin—testicular cancer	0.00306	0.00491	CcSEcCtD
Triamterene—Rash—Bleomycin—testicular cancer	0.00303	0.00487	CcSEcCtD
Triamterene—Dermatitis—Bleomycin—testicular cancer	0.00303	0.00487	CcSEcCtD
Triamterene—Hypersensitivity—Ifosfamide—testicular cancer	0.00303	0.00487	CcSEcCtD
Triamterene—Asthenia—Ifosfamide—testicular cancer	0.00295	0.00474	CcSEcCtD
Triamterene—Photosensitivity reaction—Epirubicin—testicular cancer	0.00292	0.00469	CcSEcCtD
Triamterene—Nausea—Bleomycin—testicular cancer	0.00286	0.00459	CcSEcCtD
Triamterene—Vomiting—Dactinomycin—testicular cancer	0.00285	0.00458	CcSEcCtD
Triamterene—Rash—Dactinomycin—testicular cancer	0.00283	0.00455	CcSEcCtD
Triamterene—Diarrhoea—Ifosfamide—testicular cancer	0.00281	0.00452	CcSEcCtD
Triamterene—Fatigue—Etoposide—testicular cancer	0.0028	0.0045	CcSEcCtD
Triamterene—Jaundice—Epirubicin—testicular cancer	0.00278	0.00447	CcSEcCtD
Triamterene—Dizziness—Ifosfamide—testicular cancer	0.00272	0.00437	CcSEcCtD
Triamterene—Photosensitivity reaction—Doxorubicin—testicular cancer	0.0027	0.00434	CcSEcCtD
Triamterene—Nausea—Dactinomycin—testicular cancer	0.00266	0.00428	CcSEcCtD
Triamterene—Vomiting—Ifosfamide—testicular cancer	0.00261	0.0042	CcSEcCtD
Triamterene—Hypersensitivity—Cisplatin—testicular cancer	0.00261	0.0042	CcSEcCtD
Triamterene—Rash—Ifosfamide—testicular cancer	0.00259	0.00417	CcSEcCtD
Triamterene—Dermatitis—Ifosfamide—testicular cancer	0.00259	0.00416	CcSEcCtD
Triamterene—Jaundice—Doxorubicin—testicular cancer	0.00257	0.00414	CcSEcCtD
Triamterene—Asthenia—Cisplatin—testicular cancer	0.00254	0.00409	CcSEcCtD
Triamterene—Nausea—Ifosfamide—testicular cancer	0.00244	0.00392	CcSEcCtD
Triamterene—Diarrhoea—Cisplatin—testicular cancer	0.00243	0.0039	CcSEcCtD
Triamterene—Hypersensitivity—Etoposide—testicular cancer	0.00239	0.00384	CcSEcCtD
Triamterene—Asthenia—Etoposide—testicular cancer	0.00233	0.00374	CcSEcCtD
Triamterene—Vomiting—Cisplatin—testicular cancer	0.00225	0.00362	CcSEcCtD
Triamterene—Rash—Cisplatin—testicular cancer	0.00223	0.00359	CcSEcCtD
Triamterene—Dermatitis—Cisplatin—testicular cancer	0.00223	0.00359	CcSEcCtD
Triamterene—Diarrhoea—Etoposide—testicular cancer	0.00222	0.00357	CcSEcCtD
Triamterene—Dizziness—Etoposide—testicular cancer	0.00215	0.00345	CcSEcCtD
Triamterene—Nausea—Cisplatin—testicular cancer	0.00211	0.00338	CcSEcCtD
Triamterene—Vomiting—Etoposide—testicular cancer	0.00206	0.00332	CcSEcCtD
Triamterene—Rash—Etoposide—testicular cancer	0.00205	0.00329	CcSEcCtD
Triamterene—Dermatitis—Etoposide—testicular cancer	0.00205	0.00329	CcSEcCtD
Triamterene—Headache—Etoposide—testicular cancer	0.00203	0.00327	CcSEcCtD
Triamterene—Anaphylactic shock—Methotrexate—testicular cancer	0.00194	0.00313	CcSEcCtD
Triamterene—Nausea—Etoposide—testicular cancer	0.00193	0.0031	CcSEcCtD
Triamterene—Thrombocytopenia—Methotrexate—testicular cancer	0.0019	0.00306	CcSEcCtD
Triamterene—Dry mouth—Epirubicin—testicular cancer	0.00186	0.00298	CcSEcCtD
Triamterene—Anaphylactic shock—Epirubicin—testicular cancer	0.00182	0.00292	CcSEcCtD
Triamterene—Thrombocytopenia—Epirubicin—testicular cancer	0.00178	0.00286	CcSEcCtD
Triamterene—Dry mouth—Doxorubicin—testicular cancer	0.00172	0.00276	CcSEcCtD
Triamterene—Anaphylactic shock—Doxorubicin—testicular cancer	0.00168	0.00271	CcSEcCtD
Triamterene—Fatigue—Methotrexate—testicular cancer	0.00168	0.00269	CcSEcCtD
Triamterene—Thrombocytopenia—Doxorubicin—testicular cancer	0.00165	0.00265	CcSEcCtD
Triamterene—Fatigue—Epirubicin—testicular cancer	0.00157	0.00252	CcSEcCtD
Triamterene—Fatigue—Doxorubicin—testicular cancer	0.00145	0.00233	CcSEcCtD
Triamterene—Hypersensitivity—Methotrexate—testicular cancer	0.00143	0.0023	CcSEcCtD
Triamterene—Asthenia—Methotrexate—testicular cancer	0.0014	0.00224	CcSEcCtD
Triamterene—Hypersensitivity—Epirubicin—testicular cancer	0.00134	0.00215	CcSEcCtD
Triamterene—Diarrhoea—Methotrexate—testicular cancer	0.00133	0.00214	CcSEcCtD
Triamterene—Asthenia—Epirubicin—testicular cancer	0.00131	0.0021	CcSEcCtD
Triamterene—Dizziness—Methotrexate—testicular cancer	0.00129	0.00207	CcSEcCtD
Triamterene—Diarrhoea—Epirubicin—testicular cancer	0.00125	0.002	CcSEcCtD
Triamterene—Hypersensitivity—Doxorubicin—testicular cancer	0.00124	0.00199	CcSEcCtD
Triamterene—Vomiting—Methotrexate—testicular cancer	0.00124	0.00199	CcSEcCtD
Triamterene—Rash—Methotrexate—testicular cancer	0.00123	0.00197	CcSEcCtD
Triamterene—Dermatitis—Methotrexate—testicular cancer	0.00123	0.00197	CcSEcCtD
Triamterene—Headache—Methotrexate—testicular cancer	0.00122	0.00196	CcSEcCtD
Triamterene—Asthenia—Doxorubicin—testicular cancer	0.00121	0.00194	CcSEcCtD
Triamterene—Dizziness—Epirubicin—testicular cancer	0.0012	0.00193	CcSEcCtD
Triamterene—Vomiting—Epirubicin—testicular cancer	0.00116	0.00186	CcSEcCtD
Triamterene—Nausea—Methotrexate—testicular cancer	0.00116	0.00186	CcSEcCtD
Triamterene—Diarrhoea—Doxorubicin—testicular cancer	0.00115	0.00185	CcSEcCtD
Triamterene—Rash—Epirubicin—testicular cancer	0.00115	0.00184	CcSEcCtD
Triamterene—Dermatitis—Epirubicin—testicular cancer	0.00115	0.00184	CcSEcCtD
Triamterene—Headache—Epirubicin—testicular cancer	0.00114	0.00183	CcSEcCtD
Triamterene—Dizziness—Doxorubicin—testicular cancer	0.00111	0.00179	CcSEcCtD
Triamterene—Nausea—Epirubicin—testicular cancer	0.00108	0.00174	CcSEcCtD
Triamterene—Vomiting—Doxorubicin—testicular cancer	0.00107	0.00172	CcSEcCtD
Triamterene—Rash—Doxorubicin—testicular cancer	0.00106	0.00171	CcSEcCtD
Triamterene—Dermatitis—Doxorubicin—testicular cancer	0.00106	0.0017	CcSEcCtD
Triamterene—Headache—Doxorubicin—testicular cancer	0.00106	0.0017	CcSEcCtD
Triamterene—Nausea—Doxorubicin—testicular cancer	0.001	0.00161	CcSEcCtD
